Lawrence J. Albers

Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.

Ellen J. Hess, Lawrence J. Albers, Hollister Le et al. · Journal of Pharmacology and Experimental Therapeutics · 1986 · 135 citations

Treatment-Resistance to Clozapine in Association With Ultrarapid CYP1A2 Activity and the C → A Polymorphism in Intron 1 of the CYP1A2 Gene: Effect of Grapefruit Juice and Low-Dose Fluvoxamine

Vural Özdemir, W. Kalow, Allan B. Okey et al. · Journal of Clinical Psychopharmacology · 2001 · 98 citations

CYP1A2 Activity as Measured by a Caffeine Test Predicts Clozapine and Active Metabolite Norclozapine Steady-State Concentration in Patients With Schizophrenia

Vural Özdemir, W. Kalow, Paul Posner et al. · Journal of Clinical Psychopharmacology · 2001 · 83 citations

Second-Generation Antipsychotic Exposure and Metabolic-Related Disorders in Patients With Schizophrenia

Christopher Reist, Jim Mintz, Lawrence J. Albers et al. · Journal of Clinical Psychopharmacology · 2007 · 64 citations

Psychotropic Medication, Psychopharmacology, Second-generation Antipsychotic Exposure +17

Simultaneous determination of fluvoxamine isomers and quetiapine in human plasma by means of high-performance liquid chromatography

M.A. Saracino, Laura Mercolini, G. Flotta et al. · Journal of Chromatography B · 2006 · 61 citations

Gas Chromatography, Fluvoxamine Isomers, Medicine +10